John,

For too long, Big Pharma has capitalized on taxpayer-funded research, reaping massive profits while leaving countless Americans struggling to afford basic medications. This inequity is a moral failing of our healthcare system.

But now, there's hope because new Department of Commerce guidelines assert that price is a key factor in ensuring public accessibility to medications. While this should be obvious, it’s actually a groundbreaking approach that will allow the government to license drug production to other parties when the original manufacturers fail to make them available at reasonable prices.

These proposed “march-in rights” are a major shift towards fairness and accessibility, ensuring that taxpayer-funded research benefits everyone, not just the pharmaceutical giants.

This policy shift is a direct challenge to Big Pharma, prioritizing public health and affordability over corporate profits and we must make sure it sees the light of day.

Help challenge Big Pharma's monopolistic practices. Sign and send your official comment to the Department of Commerce in support of march-in rights to lower drug prices.

Big Pharma cannot be allowed to continue to take public investments to develop drugs, only to turn around and slap astronomical prices on them, blatantly prioritizing profits over the health and well-being of the American people.

That’s what makes the Biden-Harris Administration's decisive move to employ march-in rights for taxpayer-funded drugs a key step towards a future where healthcare is a right, not a privilege.

And lowering drug prices is one of the most important fights to reclaim our healthcare system from corporate greed. This will ensure that our investment in medical research translates into affordable treatments for all.

By participating in the public comment period, you can help shape policies that will define the future of our healthcare. This is your chance to take a stand against Big Pharma and advocate for a system that values human lives over profit margins.

It's time for Big Pharma to be held accountable. Demand that the Commerce Department's plan is implemented to its full potential.

Let's ensure that taxpayer-funded drugs are accessible and affordable for all.

- Amanda

Amanda Ford, Director
Democracy for America
Advocacy Fund